#USA #AI Technology #Scottsdale #Xcellerant Ventures #DeepLook Medical

DeepLook Medical's Triumph at Venture Madness 2026

DeepLook Medical, an innovative company specializing in AI-driven imaging technology aimed at early cancer detection, has recently garnered top honors at the 2026 Venture Madness pitch competition held in Scottsdale, Arizona. This victory not only highlights their cutting-edge technology but also underscores the rapid growth and clinical advancements the company has achieved since its relocation to Arizona.

The flagship product of DeepLook Medical, a software known as DL Precise™, has received FDA clearance and is designed to aid radiologists in making precise assessments. This software employs advanced AI shape-recognition techniques to delineate the borders of tumors that are difficult to identify, especially in individuals with dense breast tissue. By providing crystal-clear visualizations, DL Precise™ enhances early-stage patient care, enabling healthcare providers to act swiftly and effectively.

DeepLook's recognition at Venture Madness, backed by the Arizona Innovation Challenge (AIC), marks a significant validation of their strategic decision to establish their operations in Phoenix. Since becoming part of the state's thriving healthcare ecosystem, the company has expanded its clinical operations, including collaborations with notable institutions such as Banner MD Anderson, which is set to lead one of their major trials focused on breast surgery and cancer detection.

CEO Marissa Fayer expressed her enthusiasm regarding the win, stating, "Winning at Venture Madness is an incredible milestone for DeepLook Medical as we work to revolutionize early breast cancer detection. Arizona offers the most supportive ecosystem we could imagine. Xcellerant Ventures has been far more than a capital partner; they brought the scientific rigor we needed to scale up, attract top-line researchers, and connect with the exact right partners and systems to advance women's health globally." This statement reflects the strong collaborative spirit in Arizona’s healthcare community, which fosters innovation and growth.

Xcellerant Ventures, the venture capital firm that has financially backed DeepLook Medical, is committed to fostering advancements in the HealthTech and MedTech sectors. Led by Managing Partner and practicing physician John Shufeldt, the firm emphasizes a hands-on approach to investment, tapping into the rich talent reservoir in Phoenix. Their first dedicated investment in women's health signifies an important milestone in their mission to drive healthcare innovation.

"DeepLook Medical's recognition at Venture Madness is a powerful testament to the life-saving potential of their AI-driven technology," noted Michael Shufeldt, General Partner at Xcellerant. He articulates the importance of integrating innovative companies into the local ecosystem, which not only benefits Arizona but enhances patient outcomes on a national scale.

Xcellerant Ventures is dedicated to establishing Arizona as a leading healthcare innovation hub. John Shufeldt has recently received accolades as the 2026 Trailblazer of the Year at the Phoenix Business Journal's AZ Inno Fire Awards, further accentuating the company’s commitment to pushing boundaries in healthcare technology.

As for DeepLook Medical, their revolutionary approach to medical imaging is transforming the way healthcare professionals detect and interpret cancers. The DL Precise™ software exemplifies their dedication to improving diagnostic capabilities, ultimately leading to better patient care. With the backing of Xcellerant Ventures and the supportive environment in Arizona, DeepLook is poised for rapid expansion and increased impact in women's health.

In conclusion, the success of DeepLook Medical at Venture Madness 2026 serves as a beacon of hope and inspiration in the healthcare technology landscape. Their journey, fueled by innovation and collaboration, showcases the promising future of AI-driven solutions in transforming patient outcomes, particularly in the realm of early cancer detection and women's health.